A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

About this Trial

Phase III Clinical Study to Evaluate the Safety and Efficacy of Elagolix in combination with Norethindrone Acetate or Estradiol/Norethindrone Acetate in Participants With Moderate to Severe Endometriosis-Associated Pain 

• Status: Enrolling now
• Location: Miami Valley Hospital
• Study type: Interventional
• Ages eligible for study: 18 to 49 years
• Genders eligible for study: Female
• Principal Investigator: Dr. Gregory Talbot
• For more information about this study, visit ClinicalTrials.gov: NCT03213457

Contact Us

If you would like information about participating in this study, contact:

Dawn Shields, BS
(937) 208-3689
dashields@premierhealth.com